Introduction
Recent developments in neurocritical care including enhanced monitoring techniques, a shift of focus to real-time normalization of pathophysiological states, and better recognition and management of complications following subarachnoid hemorrhage (SAH) have improved the level of care for SAH patients. As a result, the mortality rate decreased from 50 to 25-35% [1 ,2 ]. Advanced age, worse clinical grade, rebleeding, larger aneurysm size, global cerebral edema, delayed cerebral ischemia, and medical complications have a detrimental impact on outcome after SAH [3] [4] [5] . Reports of early and aggressive treatment of poor-grade patients demonstrated unexpected improvements of long-term functional outcome [6,7 ,8 ] . In this review, aggressive intensive care management of poor-grade subarachnoid hemorrhage patients and outcome predictors will be discussed.
Epidemiology and outcome of poor-grade subarachnoid hemorrhage patients
Poor-grade SAH patients (Hunt and Hess grade 4 and 5) encompass 18-24% of the entire SAH population and have worse long-term functional outcomes and higher mortality rates [5,7 ,8 ] . Of all clinical rating scales, the Glasgow Coma Scale (GCS) was confirmed to be the best predictor of poor long-term functional outcome [defined as modified Rankin Scale (mRS) 4-6] in this subset of patients [9] . In a Japanese study of 283 poor-grade SAH patients, 34% achieved a favorable outcome (good recovery, moderate disability on Glasgow Outcome Scale (GOS 4 and 5)) at discharge. Mortality was higher after rebleeding which mostly occurred within the first 6 h (72%). Among the poor-grade patients, outcome was worse for patients aged at least 65 years, with World Federations of Neurosurgery (WFNS) grade 5 on admission, and with an infarct due to vasospasm on computed tomography (CT). Improvement in WFNS grade was associated with favorable outcome. There was no relationship between time to aneurysm repair and functional outcome in these poor-grade patients [10 ] . In another recent retrospective study of 47 WFNS grade 4 and 5 SAH patients who underwent coiling of the ruptured aneurysm and aggressive neurocritical care, good outcome (GOS 4 and 5) at 6 months was achieved in 53% [2 ] . Of 70 vigorously treated patients with Hunt and Hess grade V SAH 35 (50%) died. Twenty-six patients received neuropsychological and quality of life analysis at 1 year. Half of the patients, mainly young and highly educated individuals, all employed in full-time jobs prior to SAH, had mild cognitive deficits and were able to live a normal life. The remaining patients had poor cognitive function (verbal and visual memory, bilateral motor function), were not able to return to work, and perceived more problems with social functioning and wellbeing. Among those, there was a trend to a higher frequency of early hydrocephalus. In general, limitations in physical health were conceived as problems by this patient population compared to emotional problems which were less problematic [8 ] . In a series of 78 treated patients with Hunt and Hess 4 and 5 SAH, 56% achieved good outcomes (GOS 4 and 5). The majority of this patient population underwent computed tomography perfusion imaging (CTP) within 24 h of symptom onset. Shorter mean transit times (MTT), larger cerebral blood volumes (CBV), and higher cerebral blood flows (CBF) were indicators of sufficient cerebral perfusion and linked with good outcome. The patients with hemispheric or global hypoperfusion on CTP had unfavorable outcomes, while the outcomes of patients with focal hypoperfusion could not be predicted [7 ] . These findings may be used as additional selection criteria to determine the level of care, but need to be confirmed in a prospective study.
Despite collaborative efforts of a team of neurosurgeons, neuroradiologists, and neurointensivists, many tend to select the good grade patients for comprehensive and aggressive treatment. Angiography and aneurysm repair get restricted to poor-grade patients showing signs of clinical improvement. The latest studies have shown that poor-grade SAH patients have the potential to recover if treated aggressively from onset through rehabilitation [11] . Therefore, prognosis of these patients will depend on the perceived outcome and determined level of care. Early neurological and cardiopulmonary resuscitation of poor-grade patients followed by high quality and comprehensive neurocritical care should be the standard and based on a team effort.
Initial resuscitation
Whereas rebleeding and symptomatic vasospasm had the greatest effect on mortality in the past [3] , the direct effect of the hemorrhage reflected in the initial clinical grade seems to become the most important factor impacting long-term outcome. Angiography, surgical and endovascular repair are readily available. Initial resuscitation of the poor-grade patient should focus on (1) control of intracranial pressure (ICP) caused by hydrocephalus and global cerebral edema; (2) stabilization of oxygenation and hemodynamics to optimize cerebral perfusion and oxygen supply; and (3) blood pressure control and seizure prophylaxis, antifibrinolytic agents to prevent aneurysm rebleeding.
The resuscitation goals of SAH management are presented in Table 1 .
Acute brain injury states
In acute SAH, the sudden rise in ICP up to levels of the mean arterial pressure (MAP) leads to an arrest of cerebral circulation which is clinically seen as loss of consciousness [12] , and to the development of global cerebral edema and acute ischemic injury on neuroimaging [3, 13, 14 ] .
Global cerebral edema, defined as complete or nearcomplete effacement of the hemispheric sulci and basal cisterns as well as bilateral and extensive disruption of the hemispheric gray-white matter junction at the level of the centrum semiovale due to either blurring or diffuse peripheral 'fingerlike' extension of the normal demarcation between gray and white matter develops more commonly in poor-grade SAH patients (44%) [15] . Patients with global cerebral edema developed signs of cerebral hypermetabolism (elevated lactate and pyruvate on microdialysis) up to 90 h after ictus [16] which may increase cerebral energy demand. This condition is linked to increased risk of death, disability, and cognitive dysfunction [3] .
Symmetric cortical ischemic injury was demonstrated in multiple vascular territories, mainly in the middle cerebral artery (MCA) and anterior cerebral artery (ACA) distributions on diffusion-weighted imaging (DWI) of poor-grade patients early after ictus by Hadeishi et al. [13] . In our series of 21 poor-grade patients 86% showed bilateral ischemic brain injury on DWI, most prominently in the bilateral ACA territories (16 patients), which was not seen on CT, see Fig. 1 . Other regions affected included the thalamus and basal ganglia (4 patients), MCA (6 patients) or posterior cerebral artery (PCA) territories (2 patients), or cerebellum (2 patients). At 1 year, 15 patients were dead (life-support had been withdrawn in 6), 2 were moderately-to-severely disabled (mRS ¼ 4), and 4 had moderate-to-no disability (mRS ¼ 1-3). Another study of 38 patients with Hunt and Kosnik grade IV and V undergoing DWI within 24 h of symptom onset before angiography and repair procedures demonstrated parenchymal DWI abnormalities in 82% of patients. Compared to patients without evidence of ischemic injury on DWI, the patients with DWI abnormalities had a lower likelihood of good outcomes (GOS 4 and 5) at 3 months. None of the patients with territorial lesions (>10 mm) on DWI achieved a good long-term outcome [14 ] . The underlying pathophysiology of the DWI abnormalities may include focal rapid and transient disturbances of microcirculatory perfusion due to intracranial hypertension leading to intracranial circulatory arrest, early vasospasm, periventricular hypoperfusion and hypoxia from gradually increased intraventricular pressure, microembolism during aneurismal rupture, global hypoperfusion and hypoxia due to neurogenic stunned myocardium and pulmonary edema, or spreading depolarization of brain cells in the cerebral cortex with microvascular vasoconstriction [13, 14 ] . This finding calls for further investigation of new resuscitation targets and strategies such as early decompressive surgery, hemodynamic support, or hypothermia.
'Ultraearly' vasospasm has been observed on angiography and linked to increased risk for delayed cerebral ischemia [17] . This phenomenon can also be detected by transcranial Doppler sonography (TCD) within 48 h of SAH onset. Elevations of mean flow velocities in the MCA more than 90 cm/s, followed by a fall more than 10 cm/s upon follow-up TCD were associated with a higher frequency of delayed cerebral ischemia in 199 SAH patients [18] .
Treatment of intracranial hypertension
Beside drainage of cerebrospinal fluid (CSF) for ICP control and monitoring, space-occupying hemorrhages should be treated by craniotomy and surgical decompression. Decompressive craniectomy is indicated in patients with life threatening cerebral edema with and without intracerebral hemorrhage, due to infarction or rebleeding and should be performed as soon as possible to avoid herniation [19] . Medical therapy of elevated ICP is listed in Table 2 . Multimodal monitoring including ICP, MAP, cerebral perfusion pressure (CPP), partial pressure of cerebral tissue oxygen ( pbtO 2 ), cerebral lactate, pyruvate, glucose, glycerol, and glutamate by microdialysis and calculation of reactivity indices may help to determine the optimal CPP threshold. The pressure reactivity index is calculated as the correlation coefficient between ICP and MAP to reflect cerebral autoregulation states. During a normal state of autoregulation the pressure reactivity index is negative. If autoregulation is disturbed, MAP changes are directly transmitted passively through a nonreactive vasculature to ICP (see Fig. 2 [20] ). In this case, the pressure reactivity index is negative. The optimal CPP was defined as the CPP at the lowest pressure reactivity index observed within a range of CPP (50-90 mmHg usually). Utilizing this concept, lower mean pressure reactivity indices during the first 48 h of SAH were correlated with increased survival at 3 months (positive predictive value 88%). Higher values for optimal CPP were observed during the vasospasm period, probably due to loss of autoregulation [21 ] .
The use of hypertonic saline (23.5%) for treatment of intracranial hypertension resulted in an increase in CBF (20-50%) in ischemic regions and in pbtO 2 in poor-grade SAH patients [22, 23] . In a study of 44 patients with WFNS grade 4 SAH, administration of 23.5% hypertonic saline at 2 ml/kg over 10-30 min led to a sustained improvement of CBF, pbtO 2 , and decrease in ICP independent of MAP up to 4 h post infusion. This favorable response to hypertonic saline was linked to a trend to better outcome (mRS 4-6) [24 ] . For these reasons, hypertonic saline may be the preferred treatment for ICP crisis.
Medical complications
In addition to the direct effects of the initial hemorrhage and secondary neurological complications, SAH also predisposes to medical complications that may have an impact on outcome [5] and increase the length of stay in the neurocritical care unit (NICU) and in the hospital [25] .
Fever Fever (38.38C) is a frequent event in patients with SAH (41-70%) [5, [26] [27] [28] [29] and associated with an increased risk of symptomatic vasospasm [28] , an increased length of NICU and hospital stay [25] , with poor outcome (mRS 4-6), dependence in activities of daily living, and cognitive impairment at 3 months [5, 28, 29] . Medical or physical fever control should be attempted (see Table 1 ). In a case-control study of advanced fever control with surface or endovascular cooling devices for 40 SAH patients, advanced fever control resulted in a lower daily fever burden and in better outcomes at 12 months (mRS 4-6 in 21%) compared to conventional fever management of 80 SAH patients (mRS 4-6 in 46%, P ¼ 0.03). The patients on advanced fever control developed hyperglycemia and arrhythmias more frequently, required intravenous sedation, mechanical ventilation, and tracheostomy more often, and had a more prolonged NICU stay. In the multivariate linear regression analysis, advanced fever control was associated with good outcomes at 12 months [30 ] . However, prospective randomized
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General principles

Anemia
Anemia treated with blood transfusions is associated with an increased risk of mortality and poor functional outcome at 3 months after SAH [5, 31] as well as with brain tissue hypoxia ( pbtO 2 15 mmHg) and metabolic distress (lactate/pyruvate ratio 40) [32] . In a safety study, 44 SAH patients were randomized to hemoglobin targets of 10 or 11.5 g/dl. Achieving the higher hemoglobin target by transfusion of packed red blood cells was found to be safe and feasible [33 ] . Nevertheless, it remains uncertain whether anemia after SAH reflects general illness severity, impacts outcome directly, or whether the treatment for anemia -blood transfusion -contributes to poor outcome [31, [34] [35] [36] .
Hyperglycemia
Admission or persistent hyperglycemia was found to be linked to symptomatic vasospasm, delayed cerebral ischemia (DCI) as well as poor short and long-term outcome (GOS 1-3, mRS 4-6) after SAH in several investigations [5, [37] [38] [39] [40] . Patients with poor-grade SAH experienced a higher degree of glucose variability during the hospital stay which was linked to worse outcomes at 3 months [41] . Retrospective studies reflecting changes of clinical practice (introduction of insulin protocols) demonstrated that achievement of good glycemic control [mean glucose burden above 7.8 mmol/l (140 mg/dl) less than 1.1 mmol/l (20 mg/dl)] significantly reduced the likelihood of poor outcome (mRS 4-6) at 3-6 months [42 ] and identified hypoglycemia (<60 mg/dl ¼ 3.3 mmol/l) as powerful independent predictor of mortality at discharge [43] . Decreasing serum glucose by 25% leads to a decline of cerebral glucose <0.7 mmol/l and an elevation of the lactate/pyruvate ratio higher than 40, for example to a metabolic cerebral crisis [44] . Clinical signs of systemic and cerebral hypoglycemia may not be obvious in poorgrade SAH patients. Therefore, hypoglycemia should be avoided while applying tight glucose control. More safety trials of intensive insulin therapy in SAH with cerebral glucose monitoring as well as efficacy studies exploring long-term outcome after SAH are needed.
Neurogenic stunned myocardium
A recent meta-analysis showed that cardiac abnormalities on ECG, echocardiography, and troponin measurements are related to DCI, poor outcome, and death after SAH (discharge -6 months follow-up period) [45] . Left ventricular dysfunction after SAH was associated with cerebral infarction [46] . Thus, hypotension and hypoxia due to depressed cardiac function and pulmonary edema should be treated aggressively utilizing vasopressors and inotropes, diuretics, and lung protective ventilation. Invasive or noninvasive hemodynamic monitoring may be warranted in these patients (see Table 1 ). Passive collapse
Zone of normal autoregulation
In the vasodilatory cascade zone, CPP insufficiency and intact pressure autoregulation leads to reflex cerebral vasodilation and increased ICP: the treatment is to raise CPP. In the autoregulation breakthrough zone, pressure and volume overload which overwhelms the brain's capacity to autoregulate leads to increased cerebral blood volume and ICP: the treatment is to lower CPP. CPP, cerebral perfusion pressure; ICP, intracranial pressure. Reproduced from [20] .
Hyponatremia
Hyponatremia occurs in 20-40% of SAH patients as a result of the syndrome of inappropriate excretion of antidiuretic hormone (SIADH), cerebral salt wasting syndrome (CSWS), or both [47] . In 124 WFNS grade 4 and 5 patients, hyponatremia (serum sodium <135 mmol/l) developed in 63%, caused by cerebral salt wasting syndrome in 55%. Late-onset hyponatremia (between SAH day 4 and 9) correlated with a higher occurrence of cerebral infarction in this patient population. Nevertheless, hyponatremia did not have an association with poor outcome at 3 months (GOS 1-3) [48 ] . As the cause of hyponatremia in SAH patients mainly includes CSWS or a combination of CSWS and SIADH, the treatment should focus on isotonic fluid replacement (see Table 1 ).
Infections
Infections frequently occurring after SAH encompass pneumonia (20%), urinary tract infections (13%), blood stream infections (8%), and bacterial meningitis/ventriculitis (5%) [4, 5] . After adjusting for length of NICU stay, advanced age, high clinical grade, and mechanical ventilation were significantly associated with pneumonia. Blood stream infections were related to mechanical ventilation, urinary tract infections to female sex and central line use, and meningitis/ventriculitis to the presence of intraventricular hemorrhage and extraventricular drainage [4] . Decrease of cerebral glucose of at least 1 mmol/l by microdialysis (sensitivity 92%, specificity 50%) combined with fever 388C or more was found to have a higher sensitivity (69%) and specificity (80%) for the diagnosis of meningitis in SAH patients than CSF chemistry and cultures [49] . Of 364 patients of the population of the CONSCIOUS-1 trial, 63% developed systemic inflammatory response syndrome (SIRS) in the first 4 days after ictus. SIRS was significantly associated with poor WFNS grade, pneumonia, administration of steroids, and poor outcome (GOS 1-3) at 3 months [50] . Therefore, nosocomial infections should be aggressively treated and prevented, and the use of steroids avoided.
Delayed cerebral ischemia
DCI is defined as development of new focal neurological signs, deterioration in level of consciousness, or the appearance of new infarction on CT or MRI when the cause was thought to be attributable to vasospasm [51 ] . This definition has been found to be more meaningful than symptomatic vasospasm (new focal deficit and/or decrease in level of consciousness due to vasospasm), especially in high-grade patients whose neurological deterioration may happen unrecognized. Prevention and management of DCI is listed in Table 1 .
Poor-grade patients require different monitoring techniques to identify secondary brain injury. Multimodal monitoring provides real-time information about brain oxygenation ( pbtO 2 by polarographic technique through Clark electrode) and metabolism (cerebral lactate, pyruvate, glucose, glycerol, and glutamate by microdialysis), cerebral perfusion (MAP-ICP ¼ CPP, CBF by thermal diffusion microprobe), and about seizures, depression of activity (alpha variability or alpha/delta ratio) or cortical spreading depression by continuous electrographic encephalography (cEEG) or intracortical electrodes. Quantitative cEEG analysis demonstrated sensitive and specific detection of DCI by reductions in alpha variability or alpha/delta ratio [52, 53] . Utilization of intracortical electrodes for monitoring was more accurate than surface cEEG and showed an alpha/delta ratio signal drop more than 25% for more than 4 h about 1-3 days before angiographic confirmation of vasospasm [54] . Cortical spreading depolarizations induce local brain tissue hypoperfusion and cerebral hypoxia, and may contribute to DCI [55 ] . pbtO 2 monitoring allows for early detection of DCI [56] . Elevations of glycerol, glutamate, and lactate/ pyruvate ratios were correlated with reductions of cerebral blood flow on positron emission tomography and DCI [57, 58] . More research for determination of multimodal monitoring thresholds with the potential to develop warning systems with the aim to prevent secondary brain injury by goal directed therapy is needed.
Determination of the level of care
Based on the therapeutic nihilism and underestimation of the recovery potential considering the prognosis of poorgrade SAH patients in the past years, physicians and family members have been placed in a difficult position to decide on the level and aggressiveness of care. Death after severe brain injury may be the result of a selffulfilling prophecy if treatment is withheld [59] . In one study of 159 poor-grade patients, efforts to predict poor outcome based on admission clinical and radiographic criteria alone would have resulted in precluding 30% of patients from therapy that had favorable long-term outcomes [6] . More recent analyses demonstrated that many poor-grade patients have the potential to recover to a perceived reasonable quality of life [2 ,7 ,8 ,10 ,11] . Aggressive treatment from the outset including aneurysm repair and optimization of cerebral perfusion is warranted in poor-grade SAH patients for a period of at least 10 days. If the patient's advanced directives call for withdrawal of active life support if poor outcome is anticipated, this may still apply after an initial period of full resuscitation without any sign of improvement or stabilization.
Conclusion
Full initial cerebral and hemodynamic resuscitation of patients with poor grade (Hunt and Hess or WFNS grade 4 and 5) is warranted and has been shown to improve long-term functional, cognitive outcomes, and quality of life. Aside from the initial severity of injury, global cerebral edema, early vasospasm, mostly symmetric acute ischemic brain injury, predominantly in the bilateral anterior cerebral artery territories, and cortical spreading depolarizations may impact outcome in the poor-grade patient, but further research is required. Aggressive management of increased ICP, optimization of CBF, prevention, monitoring, and treatment of delayed cerebral ischemia, prevention and therapy of medical complications such as hyperglycemia, anemia, fever, infections, and electrolyte abnormalities are recommended for a longer period of time before the level of care is reassessed. Real-time multimodality monitoring of cerebral metabolism, brain tissue oxygenation, CBF, and electrocortical activity may provide the opportunity for early brain goal-directed therapy to prevent secondary insults after SAH. Definite studies are needed to evaluate the mechanism and impact of early ischemic brain injury, cortical spreading depolarizations, and early vasospasm, the effect of normothermia, normoglycemia, treatment of anemia as well as treatment and prevention of other complications on long-term outcome in the poor-grade SAH patients.
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